Transcriptomics and network pharmacology reveal the potential mechanism related to integrated stress response in the treatment of osteoporosis by Jiawei Shentong Zhuyu Decoction and verified by RT-qPCR

转录组学和网络药理学揭示了加味参通竹郁汤治疗骨质疏松症的潜在机制,并经RT-qPCR验证,该机制与整合应激反应相关。

阅读:1

Abstract

BACKGROUND: Osteoporosis (OP) is a systemic skeletal disorder. The molecular mechanisms underlying the effects of Jia Wei Shentong Zhuyu Decoction (JWSTZYD) and the integrated stress response (ISR) in OP remain unclear. This study aims to elucidate the mechanisms by which JWSTZYD and ISR contribute to OP. METHODS: Potential drug target genes for JWSTZYD and OP-related datasets were sourced from the Gene Expression Omnibus (GEO) and Traditional Chinese Medicine Systems Pharmacology (TCMSP) databases. Differentially expressed genes (DEGs) in OP were identified by analyzing transcriptome data. Candidate genes were selected by intersecting target genes, DEGs, and ISR-related genes (ISR-RGs), with further screening based on expression levels in OP and control samples. The potential mechanisms of these biomarkers in OP were explored through gene set enrichment analysis (GSEA), immune infiltration analysis, molecular regulatory networks, and molecular docking. Expression levels of biomarkers were validated using clinical samples. RESULTS: COL4A6 and NKX3-1 were identified as biomarkers associated with ISR in JWSTZYD treatment of OP. These biomarkers were significantly enriched in 22 and 23 pathways, respectively. Immune infiltration analysis revealed 10 differentially abundant immune cell types between OP and control. Further analysis showed that 16 transcription factors (TFs), 26 miRNAs, and 342 lncRNAs had potential interactions with the biomarkers. TFs such as FOXC1, USF2, NFYA, SRF, and NFIC were co-regulated by the biomarkers. Quercetin was identified as a drug that co-acted with these biomarkers, demonstrating strong binding affinity with both COL4A6 and NKX3-1, with binding energies of -6.3 kcal/mol and -15.7 kcal/mol, respectively. Experimental validation confirmed that the biomarkers were expressed at levels consistent with those predicted. CONCLUSION: This study identified COL4A6 and NKX3-1 as key biomarkers, providing new insights into the mechanisms associated with ISR in the treatment of OP using JWSTZYD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。